Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Kenvue Inc (KVUE)

Kenvue Inc (KVUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 45,419,820
  • Shares Outstanding, K 1,917,257
  • Annual Sales, $ 15,444 M
  • Annual Income, $ 1,664 M
  • EBIT $ 1,818 M
  • EBITDA $ 2,445 M
  • 60-Month Beta 1.36
  • Price/Sales 2.94
  • Price/Cash Flow 15.09
  • Price/Book 4.27

Options Overview Details

View History
  • Implied Volatility 18.96% ( -1.08%)
  • Historical Volatility 24.84%
  • IV Percentile 1%
  • IV Rank 1.72%
  • IV High 49.83% on 12/13/23
  • IV Low 18.42% on 09/03/24
  • Put/Call Vol Ratio 1.33
  • Today's Volume 3,225
  • Volume Avg (30-Day) 17,262
  • Put/Call OI Ratio 0.78
  • Today's Open Interest 208,740
  • Open Int (30-Day) 277,834

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.25
  • Number of Estimates 6
  • High Estimate 0.27
  • Low Estimate 0.22
  • Prior Year 0.31
  • Growth Rate Est. (year over year) -19.35%

Price Performance

See More
Period Period Low Period High Performance
1-Month
22.04 +7.89%
on 11/07/24
24.13 -1.45%
on 11/15/24
+2.06 (+9.48%)
since 10/18/24
3-Month
21.23 +12.01%
on 08/22/24
24.13 -1.45%
on 11/15/24
+2.23 (+10.35%)
since 08/20/24
52-Week
17.67 +34.58%
on 07/11/24
24.13 -1.45%
on 11/15/24
+4.03 (+20.41%)
since 11/20/23

Most Recent Stories

More News
J&J Loses Around $24B in a Month: How to Play the Stock?

J&J JNJ stock has plunged 6.1% in a month, losing almost $24 billion of its market value.Though slowing sales in its MedTech segment, the upcoming patent expiration of its blockbuster drug, Stelara, and...

NVO : 105.27 (+2.57%)
JNJ : 153.11 (+0.07%)
LLY : 753.41 (+3.25%)
KVUE : 23.78 (+0.38%)
Kenvue (KVUE) Q3 2024 Earnings Call Transcript

KVUE earnings call for the period ending September 30, 2024.

KVUE : 23.78 (+0.38%)
Kenvue: Q3 Earnings Snapshot

Kenvue: Q3 Earnings Snapshot

KVUE : 23.78 (+0.38%)
Kenvue Canada Expands Ontario Manufacturing Facility to Boost Production of Over-the-Counter Medicines

/CNW/ - Kenvue Canada Inc., a division of Kenvue Inc. (NYSE: KVUE) ("Kenvue"), the world's largest pure-play consumer health company by revenue and maker of...

KVUE : 23.78 (+0.38%)
Are Wall Street Analysts Bullish on Kenvue Stock?

Kenvue has lagged the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.

$SPX : 5,917.11 (unch)
KVUE : 23.78 (+0.38%)
XLP : 80.22 (-0.51%)
This Big New Development Could Be Bullish for Kenvue Stock

Can tinkering around the edges actually make this stock more attractive?

KVUE : 23.78 (+0.38%)
PFE : 24.94 (-0.64%)
3 Dividend Stocks to Double Up on Right Now

While tech-based growth stocks might seem like the right play, you can't ignore dividends if you want to have a strong portfolio.

F : 10.73 (-2.90%)
XOM : 120.32 (+1.42%)
KVUE : 23.78 (+0.38%)
Billionaire Ken Griffin Just Increased His Position in This Dividend Stock by 5,848%. Here's Why Now May Be a Great Time to Buy.

Ken Griffin's Citadel just added 18 million shares of an under-the-radar consumer health stock.

KVUE : 23.78 (+0.38%)
Meet the 3.6%-Yielding Dividend King Stock That's Up 25% in 3 Months

An activist investor is taking a stake in Kenvue stock.

KVUE : 23.78 (+0.38%)
Is Kenvue Stock a Buy Now?

The growth rate of the consumer healthcare business could accelerate now that an activist investor is involved.

KVUE : 23.78 (+0.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Kenvue Inc. is a pure-play consumer health company. Its brand portfolio includes AVEENO(R), BAND-AID(R) Brand Adhesive Bandages, JOHNSON'S(R), LISTERINE(R), NEUTROGENA(R), TYLENOL(R) and ZYRTEC(R). Kenvue Inc. is based in SKILLMAN, N.J.

See More

Key Turning Points

3rd Resistance Point 24.07
2nd Resistance Point 23.93
1st Resistance Point 23.85
Last Price 23.78
1st Support Level 23.63
2nd Support Level 23.49
3rd Support Level 23.42

See More

52-Week High 24.13
Last Price 23.78
Fibonacci 61.8% 21.66
Fibonacci 50% 20.90
Fibonacci 38.2% 20.14
52-Week Low 17.67

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar